GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 44.30
+2.32 (5.53%)
At close: Jul 20, 2025
GlaxoSmithKline S.A.E Company Description
GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines.
GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom.
GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.
GlaxoSmithKline S.A.E
| Country | Egypt |
| Founded | 1981 |
| Industry | Pharmaceutical Preparations |
| Employees | 800 |
| CEO | Hassan Fahmi |
Contact Details
Address: 79 New Oxford Street London, WC1A 1DG United Kingdom | |
| Phone | 44 20 8047 5000 |
| Website | gsk.com |
Stock Details
| Ticker Symbol | BIOC |
| Exchange | Egyptian Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EGP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hassan Fahmi | Chief Executive Officer |
| Vikas Jain | Chief Financial Officer |
| Mohsen Taoufils | Head of Investor Relations |